{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:09:05Z","timestamp":1789715345995,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.ejca.2012.02.047","type":"journal-article","created":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T17:30:36Z","timestamp":1331314236000},"page":"949-960","source":"Crossref","is-referenced-by-count":68,"title":["Rare thoracic cancers, including peritoneum mesothelioma"],"prefix":"10.1016","volume":"48","author":[{"given":"Sabine","family":"Siesling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Maarten van der","family":"Zwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Izarzugaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Jaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Treasure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Foschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tavilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Ardanaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"160","key":"10.1016\/j.ejca.2012.02.047_b0010","first-page":"68","article-title":"Cancer incidence in five continents. Volume IX","author":"Curado","year":"2007","journal-title":"IARC Sci Publ"},{"issue":"5","key":"10.1016\/j.ejca.2012.02.047_b0015","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1080\/02841860902913546","article-title":"Occupation and cancer \u2013 follow-up of 15 million people in five Nordic countries","volume":"48","author":"Pukkala","year":"2009","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2012.02.047_b0020","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cncr.10665","article-title":"New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China","volume":"95","author":"Chen","year":"2002","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2012.02.047_b0025","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/1097-0142(19940715)74:2<606::AID-CNCR2820740212>3.0.CO;2-T","article-title":"Thymoma. Histologic subclassification is an independent prognostic factor","volume":"74","author":"Quintanilla-Martinez","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2012.02.047_b0030","series-title":"International classification of disease for oncology","author":"Fritz","year":"2000"},{"key":"10.1016\/j.ejca.2012.02.047_b0035","unstructured":"Gatta, van der Zwan, Siesling, et al. Technical report with basic indicators for rare cancers and health care related macro indicators. rarecare 2010 June 9. Available from: <http:\/\/www.rarecare.eu\/rare_indicators\/WP5_Technical_Report.pdf>."},{"issue":"4","key":"10.1016\/j.ejca.2012.02.047_b0040","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2307\/2529873","article-title":"Cancer survival corrected for heterogeneity in patient withdrawal","volume":"38","author":"Hakulinen","year":"1982","journal-title":"Biometrics"},{"issue":"2","key":"10.1016\/j.ejca.2012.02.047_b0045","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/ije\/31.2.456","article-title":"Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland","volume":"31","author":"Brenner","year":"2002","journal-title":"Int J Epidemiol"},{"issue":"6","key":"10.1016\/j.ejca.2012.02.047_b0050","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/annonc\/mdf152","article-title":"Measuring cancer prevalence in Europe: the EUROPREVAL project","volume":"13","author":"Capocaccia","year":"2002","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2012.02.047_b0055","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<425::AID-SIM414>3.0.CO;2-Z","article-title":"Estimating the completeness of prevalence based on cancer registry data","volume":"16","author":"Capocaccia","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2012.02.047_b0060","unstructured":"Table; The inhabitants of a given area on 1 January of the year in question. EUROSTAT 2009 April 2. Available from: <http:\/\/epp.eurostat.ec.europa.eu\/portal\/page\/portal\/eurostat\/home\/>."},{"issue":"17","key":"10.1016\/j.ejca.2012.02.047_b0065","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.ejca.2011.08.008","article-title":"Rare cancers are not so rare: the rare cancer burden in Europe","volume":"47","author":"Gatta","year":"2011","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2012.02.047_b0070","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ejca.2008.11.003","article-title":"The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis","volume":"45","author":"De","year":"2009","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.ejca.2012.02.047_b0075","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/thx.2007.095067","article-title":"Pulmonary tumours in the Netherlands: focus on temporal trends in histology and stage and on rare tumours","volume":"63","author":"de Jong","year":"2008","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.ejca.2012.02.047_b0080","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S1470-2045(05)70471-X","article-title":"Survival from rare cancer in adults: a population-based study","volume":"7","author":"Gatta","year":"2006","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2012.02.047_b0085","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1023\/A:1026300619747","article-title":"Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends","volume":"14","author":"Montanaro","year":"2003","journal-title":"Cancer Causes Control"},{"issue":"8949","key":"10.1016\/j.ejca.2012.02.047_b0090","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(95)90462-X","article-title":"Continuing increase in mesothelioma mortality in Britain","volume":"345","author":"Peto","year":"1995","journal-title":"Lancet"},{"issue":"3\u20134","key":"10.1016\/j.ejca.2012.02.047_b0095","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/sj.bjc.6690105","article-title":"The European mesothelioma epidemic","volume":"79","author":"Peto","year":"1999","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2012.02.047_b0100","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/jes.2009.56","article-title":"Assessment of cancer risks due to environmental exposure to asbestos","volume":"20","author":"Driece","year":"2010","journal-title":"J Expo Sci Environ Epidemiol"},{"issue":"12","key":"10.1016\/j.ejca.2012.02.047_b0105","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/oem.51.12.804","article-title":"Malignant mesothelioma: attributable risk of asbestos exposure","volume":"51","author":"Spirtas","year":"1994","journal-title":"Occup Environ Med"},{"issue":"7","key":"10.1016\/j.ejca.2012.02.047_b0110","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/oem.57.7.488","article-title":"Future trends in mortality of French men from mesothelioma","volume":"57","author":"Banaei","year":"2000","journal-title":"Occup Environ Med"},{"issue":"3","key":"10.1016\/j.ejca.2012.02.047_b0115","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/sj.bjc.6605781","article-title":"Projection of mesothelioma mortality in Britain using Bayesian methods","volume":"103","author":"Tan","year":"2010","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2012.02.047_b0120","first-page":"209","article-title":"A primary squamous cell carcinoma of the trachea: case report and review of the literature","volume":"30","author":"Abbate","year":"2010","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"2","key":"10.1016\/j.ejca.2012.02.047_b0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jamcollsurg.2005.09.016","article-title":"Primary tracheal malignant neoplasms: the University of Texas MD Anderson Cancer Center experience","volume":"202","author":"Webb","year":"2006","journal-title":"J Am Coll Surg"},{"issue":"2","key":"10.1016\/j.ejca.2012.02.047_b0130","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1245\/s10434-006-9229-z","article-title":"Incidence and treatment of tracheal cancer: a nationwide study in the Netherlands","volume":"14","author":"Honings","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2012.02.047_b0135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1010-7940(01)00597-8","article-title":"Tracheal cancer in Denmark: a nationwide study","volume":"19","author":"Licht","year":"2001","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"10.1016\/j.ejca.2012.02.047_b0140","first-page":"27","article-title":"Anti-smoking policies and practice in Scottish Health Boards: progress 1985\u201389. Scottish Tobacco Group","volume":"49","author":"Crofton","year":"1991","journal-title":"Health Bull (Edinb)"},{"issue":"5","key":"10.1016\/j.ejca.2012.02.047_b0145","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00008469-199810000-00006","article-title":"Maintaining a smoke-free policy: an observational and interview study at a university hospital in Sweden","volume":"7","author":"Tillgren","year":"1998","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"10.1016\/j.ejca.2012.02.047_b0150","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/COC.0b013e3181cae8ab","article-title":"Population based cancer registry analysis of primary tracheal carcinoma","volume":"34","author":"Urdaneta","year":"2011","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2012.02.047_b0155","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.athoracsur.2004.05.064","article-title":"Long-term survival after resection of primary adenoid cystic and squamous cell carcinoma of the trachea and carina","volume":"78","author":"Gaissert","year":"2004","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.ejca.2012.02.047_b0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0003-4975(90)90358-D","article-title":"Primary tracheal tumors: treatment and results","volume":"49","author":"Grillo","year":"1990","journal-title":"Ann Thorac Surg"},{"issue":"7","key":"10.1016\/j.ejca.2012.02.047_b0165","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3109\/00016480903403005","article-title":"Clinical aspects and treatment of primary tracheal malignancies","volume":"130","author":"Honings","year":"2010","journal-title":"Acta Otolaryngol"},{"issue":"4","key":"10.1016\/j.ejca.2012.02.047_b0170","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.11099","article-title":"Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies","volume":"105","author":"Engels","year":"2003","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2012.02.047_b0175","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/S0003-4975(03)01017-8","article-title":"Lymphogenous and hematogenous metastasis of thymic epithelial tumors","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"10.1016\/j.ejca.2012.02.047_b0180","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1495::AID-CNCR4>3.0.CO;2-O","article-title":"Thymoma: prognostic factors and treatment outcomes","volume":"83","author":"Gripp","year":"1998","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2012.02.047_b0185","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0022-5223(99)70343-0","article-title":"Results of surgical treatment of thymomas with special reference to the involved organs","volume":"117","author":"Okumura","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.ejca.2012.02.047_b0190","first-page":"900","article-title":"Editorial comment recurrence of thymoma","volume":"40","author":"Ruffini","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"10.1016\/j.ejca.2012.02.047_b0195","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0360-3016(99)00514-3","article-title":"Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study","volume":"46","author":"Myojin","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejca.2012.02.047_b0200","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-5223(96)70265-9","article-title":"Prognostic factors and long-term results after thymoma resection: a series of 307 patients","volume":"112","author":"Regnard","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.ejca.2012.02.047_b0205","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0003-4975(92)91391-L","article-title":"Adjuvant radiotherapy after complete resection of thymoma","volume":"54","author":"Haniuda","year":"1992","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.ejca.2012.02.047_b0210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.thorsurg.2010.08.010","article-title":"Thymic carcinoma: is it a separate entity? From molecular to clinical evidence","volume":"21","author":"Marx","year":"2011","journal-title":"Thorac Surg Clin"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912001840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912001840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T06:00:09Z","timestamp":1543125609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804912001840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0959804912001840"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2012.02.047","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}